Fluosol-DA in radiation therapy.
D000818:Animals; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005466:Fluorocarbons / Q000627:therapeutic use*; D006895:Hydroxyethyl Starch Derivatives; D006931:Hyperbaric Oxygenation; D000860:Hypoxia / Q000628:therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy* / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use
D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; D011838:Radiation-Sensitizing Agents; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination